Marin M, Tailor C S, Nouri A, Kabat D
Department of Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland, Oregon 97201-3098, USA.
J Virol. 2000 Sep;74(17):8085-93. doi: 10.1128/jvi.74.17.8085-8093.2000.
The baboon endogenous retrovirus (BaEV) belongs to a large, widely dispersed interference group that includes the RD114 feline endogenous virus and primate type D retroviruses. Recently, we and another laboratory independently cloned a human receptor for these viruses and identified it as the human sodium-dependent neutral amino acid transporter type 2 (hASCT2). Interestingly, mouse and rat cells are efficiently infected by BaEV but only become susceptible to RD114 and type D retroviruses if the cells are pretreated with tunicamycin, an inhibitor of protein N-linked glycosylation. To investigate this host range difference, we cloned and analyzed NIH Swiss mouse ASCT2 (mASCT2). Surprisingly, mASCT2 did not mediate BaEV infection, which implied that mouse cells might have an alternative receptor for this virus. In addition, elimination of the two N-linked oligosaccharides from mASCT2 by mutagenesis, as substantiated by protein N-glycosidase F digestions and Western immunoblotting, did not enable it to function as a receptor for RD114 or type D retroviruses. Based on these results, we found that the related ASCT1 transporters of humans and mice are efficient receptors for BaEV but are relatively inactive for RD114 and type D retroviruses. Furthermore, elimination of the two N-linked oligosaccharides from extracellular loop 2 of mASCT1 by mutagenesis enabled it to function as an efficient receptor for RD114 and type D retroviruses. Thus, we infer that the tunicamycin-dependent infection of mouse cells by RD114 and type D retroviruses is caused by deglycosylation of mASCT1, which unmasks previously buried sites for viral interactions. In contrast, BaEV efficiently employs the glycosylated forms of mASCT1 that occur normally in untreated mouse cells.
狒狒内源性逆转录病毒(BaEV)属于一个庞大且广泛分布的干扰组,该组包括RD114猫内源性病毒和灵长类D型逆转录病毒。最近,我们和另一个实验室独立克隆了这些病毒的人类受体,并将其鉴定为人类钠依赖性中性氨基酸转运体2型(hASCT2)。有趣的是,小鼠和大鼠细胞能被BaEV有效感染,但只有在用衣霉素(一种蛋白质N-连接糖基化抑制剂)预处理后,才会对RD114和D型逆转录病毒敏感。为了研究这种宿主范围差异,我们克隆并分析了NIH瑞士小鼠ASCT2(mASCT2)。令人惊讶的是,mASCT2不介导BaEV感染,这意味着小鼠细胞可能有该病毒的替代受体。此外,通过诱变从mASCT2中去除两个N-连接寡糖,经蛋白质N-糖苷酶F消化和Western免疫印迹证实,这并没有使其能够作为RD114或D型逆转录病毒的受体发挥作用。基于这些结果,我们发现人类和小鼠的相关ASCT1转运体是BaEV的有效受体,但对RD114和D型逆转录病毒相对无活性。此外,通过诱变从mASCT1的细胞外环2中去除两个N-连接寡糖,使其能够作为RD114和D型逆转录病毒的有效受体发挥作用。因此,我们推断RD114和D型逆转录病毒对小鼠细胞的衣霉素依赖性感染是由mASCT1的去糖基化引起的,这暴露了以前被掩盖的病毒相互作用位点。相比之下,BaEV有效地利用了未处理小鼠细胞中正常存在的mASCT1糖基化形式。